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Summary
 
Lipopolysaccharide (LPS) from gram-negative bacteria causes polyclonal activation of B cells
and stimulation of macrophages and other APC. We show here that, under in vivo conditions,
LPS also induces strong stimulation of T cells. As manifested by CD69 upregulation, LPS in-
jection stimulates both CD4 and CD8
 
 
 
 T cells, and, at high doses, stimulates naive (CD44
 
lo
 
)
cells as well as memory (CD44
 
hi
 
) cells. However, in terms of cell division, the response of T
cells after LPS injection is limited to the CD44
 
hi
 
 subset of CD8
 
 
 
 cells. In contrast with B cells,
proliferative responses of CD44
 
hi
 
 CD8
 
 
 
 cells require only very low doses of LPS (10 ng). Based
on studies with LPS-nonresponder and gene-knockout mice, LPS-induced proliferation of
CD44
 
hi
 
 CD8
 
 
 
 cells appears to operate via an indirect pathway involving LPS stimulation of
APC and release of type I (
 
 
 
, 
 
 
 
) interferon (IFN-I). Similar selective stimulation of CD44
 
hi
 
CD8
 
 
 
 cells occurs in viral infections and after injection of IFN-I, implying a common mecha-
nism. Hence, intermittent exposure to pathogens (gram-negative bacteria and viruses) could
contribute to the high background proliferation of memory–phenotype CD8
 
 
 
 cells found in
normal animals.
 
C
 
D4
 
 
 
 and CD8
 
 
 
 T cells can be subdivided into naive
and memory cells on the basis of various surface mark-
ers, especially CD44, CD45RB, and CD62L (
 
l
 
-selectin) (1).
Thus, naive T cells express a CD44
 
lo
 
 CD45RB
 
hi
 
 CD62L
 
hi
 
phenotype, whereas most memory cells are CD44
 
hi
 
 CD45-
RB
 
lo
 
 CD62L
 
lo
 
. T cells with a naive phenotype are resting
cells and show a very slow turnover as measured by incor-
poration of the DNA precursor, bromodeoxyuridine (BrdU)
(2, 3). By contrast, the majority of memory–phenotype cells
have a rapid turnover.
T cells with a memory–phenotype are presumed to be
the progeny of naive T cells responding to specific antigen.
Why these cells show a high rate of turnover is unclear.
The most obvious possibility is that memory–phenotype
cells are engaged in chronic, low level proliferative re-
sponses to residual depots of specific antigen and/or to
cross-reactive environmental antigens (4, 5). In addition to
such TCR-mediated stimulation, memory–phenotype cells
may also be subject to nonantigen–specific stimulation via
cytokines. In support of this idea, infection of mice with vi-
ruses such as lymphocytic choriomeningitis virus (LCMV)
 
1
 
causes an intense T proliferative response, which appears to
be predominantly nonantigen specific (6–8). This bystander
response preferentially affects memory–phenotype (CD44
 
hi
 
)
CD8
 
 
 
 cells and can be mimicked by injection of type I (
 
 
 
,
 
 
 
) interferon (IFN-I) and by Poly I:C, an inducer of IFN-I
(9). These findings suggest that the constant proliferation of
memory–phenotype T cells seen in normal animals may be
mediated in part by IFN-I and other cytokines released
during contact with various infectious agents. If so, any mi-
croorganism capable of stimulating IFN-I production in
vivo would be expected to cause bystander stimulation of
T cells.
To assess this possibility, we have examined the effects of
injecting mice with LPS, a component of the cell wall of
gram-negative bacteria (10). LPS (endotoxin) is well known
for its capacity to cause polyclonal activation of B cells.
However, in addition, LPS is strongly stimulatory for APC
such as macrophages, and induces these cells to release var-
ious cytokines, e.g., IFN-I, TNF-
 
 
 
, and IL-12 (11–13).
Hence, the production of these cytokines might be ex-
pected to stimulate T cells. In line with this prediction, ev-
idence is presented that even small doses of LPS cause
marked proliferation of CD44
 
hi
 
 CD8
 
 
 
 cells in vivo.
 
Materials and Methods
 
Mice and Treatments.
 
C57BL/6J (B6) mice were purchased from
either the rodent breeding colony at The Scripps Research Insti-
tute or The Jackson Laboratory (Bar Harbor, ME). C3H/HeOuJ,
C3H/HeJ, B cell–deficient (
 
 
 
MT), and IFN-
 
 
 
–deficient (IFN-
 
 
 
 
 
/
 
 
 
) mice were purchased from The Jackson Laboratory. 129/
SvEvTacfBR (129) mice were purchased from Taconic Farms
(Germantown, NY). 129 background mice defective in IFN-
 
 
 
/
 
 
 
receptor function (IFN-IR
 
 
 
/
 
 
 
) (14) were originally purchased
from B&K Universal (North Humberside, UK) and were main-
tained and bred in the animal facility at The Scripps Research In-
stitute. Where indicated, mice were injected intravenously with
LPS (from 
 
Escherichia coli
 
 serotype 055:B5, prepared by trichloro-
acetic acid extraction) (Sigma Chemical Co., St. Louis, MO) or
 
1
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Poly I:C (Sigma Chemical Co.) dissolved in 0.2 ml PBS. For bro-
modeoxyuridine (BrdU) treatment, mice were given sterile drinking
water containing 0.8 mg/ml BrdU (Sigma Chemical Co.). BrdU-
containing drinking water was changed daily.
 
Spleen Cell Transfer.
 
Spleens from C3H/HeOuJ mice were
disrupted using a tissue homogenizer and the resulting cell sus-
pension was depleted of T cells by treatment with anti-CD8 and
anti-CD4 mAbs plus complement (15). After antibody and com-
plement treatment, cells were washed three times and resus-
pended in PBS. Cells were injected intravenously in a final vol-
ume of 0.5 ml (2.3 
 
 
 
 10
 
8
 
 cells/recipient) into C3H/HeJ mice.
 
Flow Cytometry.
 
mAbs used for cell surface staining were the
following: anti-CD8–PE (GIBCO BRL, Gaithersburg, MD),
anti-CD4–PE (Collaborative Biomedical Products, Bedford, MA),
anti-Ly-6C–biotin (PharMingen, San Diego, CA), anti-B220–PE
(PharMingen), anti-CD69–biotin (PharMingen), anti-CD44–
FITC (PharMingen), and anti-CD44–biotin (IM7.8.1).
Biotinylated antibodies were detected with RED670–strepta-
vidin (GIBCO BRL). Staining for BrdU with anti-BrdU–FITC
(Becton Dickinson, Mountain View, CA) was done as described
(3). Stained cells were analyzed on a FACScan
 

 
 flow cytometer
(Becton Dickinson).
 
Results
 
Effects of LPS on Normal Mice.
 
To examine the effects of
LPS on T cell turnover, normal adult C57BL/6 (B6) mice
were injected intravenously with graded doses of LPS and
immediately placed on BrdU water. After 3 d, suspensions
of spleen and LN cells were stained for expression of cell
surface markers, fixed, and then stained for BrdU incorpo-
ration (see Materials and Methods). The data shown below
are representative of at least two separate experiments.
As expected, LPS injection caused significant prolifera-
tion of B cells, especially in spleen (Fig. 1). However, rela-
tive to the background proliferation in uninjected mice,
BrdU incorporation by B cells was only seen after injection
of relatively high doses of LPS (
 
 
 
10 
 
 
 
g). For T cells, LPS
injection had minimal effects on CD4
 
 
 
 cells. Thus, even
high doses of LPS had no effect on naive (CD44
 
lo
 
) CD4
 
 
 
cells and caused only a slight increase in the high (30%) back-
ground rate of proliferation of memory–phenotype (CD44
 
hi
 
)
cells. Quite different results applied to CD8
 
 
 
 cells. As for
CD4
 
 
 
 cells, LPS injection did not alter the slow turnover
of CD44
 
lo
 
 cells. However, even very low doses of LPS (10
ng) caused substantial proliferation of CD44
 
hi
 
 CD8
 
 
 
 cells,
both in spleen and LN; with higher doses of LPS, BrdU la-
beling of CD44
 
hi
 
 CD8
 
 
 
 cells reached 70% (compared with
20% in uninjected mice). Significantly, LPS injection caused a
considerable increase in Ly6C expression on CD8
 
 
 
 cells.
Upregulation of Ly6C expression on (total) CD8
 
 
 
 cells is
prominent in mice injected with Poly I:C and IFN-I and is
reported to be controlled specifically by IFN-I (16). Hence,
the upregulation of Ly6C on CD8
 
 
 
 cells after LPS injec-
tion signified the production of IFN-I.
 
Role of B Cells.
 
To examine whether stimulation of CD8
 
 
 
T cells by LPS required B cells, we examined the effects of
injecting LPS into B cell–deficient 
 
 
 
MT mice. As shown
in Fig. 2, BrdU labeling of CD44
 
hi
 
 CD8
 
 
 
 cells after LPS
injection was almost as high in B6 
 
 
 
MT mice as in normal
B6 mice. These data indicate that stimulation of CD8
 
 
 
cells by LPS does not require the presence of B cells.
 
T Cell Responses in LPS-nonresponder Mice.
 
In the case of
B cells, the C3H/HeJ strain of mice is largely refractory to
stimulation by LPS (17). To test whether the LPS-nonre-
sponder status of C3H/HeJ mice applies to T cells, we ex-
Figure 1. Effect of LPS injection on T and
B cell proliferation in vivo. Graded doses of
LPS were injected intravenously into B6
mice. Mice were immediately given BrdU
in their drinking water, and LN and spleen
cells were analyzed 3 d later. The three left-
most columns show percent BrdU labeling
for CD44hi ( ) and CD44lo ( ) CD8  and
CD4  cells and total B220  cells ( ), while
the right hand panel shows the percentage
of total CD8  cells expressing high levels of
Ly-6C (Ly-6Chi). The data represent mean
values from two or three mice per point
(  SD).
Figure 2. LPS induction of T cell proliferation in B cell–deficient mice.
PBS or LPS (12.5  g) was injected intravenously into B6 or  MT mice,
and mice were given BrdU in their drinking water for 3 d. Percent BrdU
labeling is shown for CD8  CD44hi and CD8  CD44lo LN (left) and
spleen (right) cells. Data represent mean values from two mice (  SD). 
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amined the effects of injecting LPS into C3H/HeJ versus
LPS-responder C3H/HeOuJ mice; injection of Poly I:C
was used as a control. As shown in Fig. 3, BrdU labeling of
CD44
 
hi
 
 CD8
 
 
 
 cells after injection of a relatively high dose
of LPS (12.5 
 
 
 
g) was prominent in C3H/HeOuJ mice but
virtually undetectable in C3H/HeJ mice; similar findings
applied to upregulation of Ly6C expression. By contrast,
injection of Poly I:C caused BrdU labeling of CD8
 
 
 
 cells
and Ly6C upregulation in both strains of mice. These data
indicate that the defective response of C3H/HeJ mice to
LPS applies to T cells.
If T cell stimulation induced by LPS injection reflects
cytokine production by APC rather than direct binding of
LPS to T cells, reconstituting C3H/HeJ mice with normal
LPS-responder APC would be expected to restore the re-
sponse of T cells to LPS. To examine this question, C3H/
HeJ mice were injected intravenously with large numbers
of T-depleted spleen cells taken from normal C3H/HeOuJ
mice 
 
 
 
 LPS. As shown in Fig. 4, the presence of normal
spleen APC at the time of LPS injection led to significant
stimulation of the host C3H/HeJ CD44
 
hi
 
 CD8
 
 
 
 cells, es-
pecially in spleen. The failure of LPS-nonresponder T cells
to proliferate after LPS injection could thus be restored by
coinjecting normal APC.
 
Role of Receptors for IFN-I.
 
The above findings suggest
that stimulation of T cells after LPS injection requires a di-
rect action of LPS on APC, presumably leading to the pro-
duction of stimulatory cytokines. To examine whether
IFN-I is required for LPS-induced T cell proliferation, we
examined the effects of injecting LPS into mice lacking re-
ceptors for IFN-I (IFN-IR
 
 
 
 mice); mice lacking the gene
for IFN-
 
 
 
 (IFN-
 
 
 
 
 
 mice) were used as a control. As shown
in Fig. 5, injecting an intermediate dose of 1 
 
 
 
g of LPS
caused prominent proliferation of CD44
 
hi
 
 CD8
 
 
 
 cells in
IFN-
 
 
 
 
 
 hosts (Fig. 5 
 
B
 
) but virtually no proliferation in
IFN-IR
 
 
 
 hosts (Fig. 5 
 
A
 
). However, a higher dose of 12.5
 
 
 
g LPS did cause substantial proliferation of CD8
 
 
 
 cells in
IFN-IR
 
 
 
 mice, as well as in IFN-
 
 
 
 
 
 mice. These findings
indicate that IFN-I production does play a crucial role in
LPS stimulation of T cells, though only with a moderate
dose of LPS. It should be noted that LPS-induced prolifer-
ation of B cells was not reduced in IFN-IR  mice, imply-
ing that the response of B cells does not require IFN-I (data
not shown).
Figure 3. Failure of LPS to in-
duce T cell proliferation in LPS-
nonresponder mice. PBS ( ),
LPS (12.5  g) ( ), or Poly I:C
(100  g) ( ) was injected intra-
venously into C3H/HeOuJ
(LPS-responder,  left) or C3H/
HeJ (LPS-nonresponder, right)
mice. Mice were given BrdU in
their drinking water for 3 d, then
CD8  LN (upper) and spleen
(lower) cells were assayed for
BrdU labeling and Ly-6C ex-
pression. Data represent the mean
values from two mice (  SD).
Figure 4. LPS induction of CD8  T cell proliferation in LPS-non-
responder mice supplemented with T-depleted spleen cells from LPS-
responder mice. T-depleted C3H/HeOuJ spleen cells (2.3   108 cells/re-
cipient) were injected intravenously into C3H/HeJ mice. 1 d later, the
recipients were injected with PBS ( ) or 12.5  g LPS ( ) and then
given BrdU water for 3 d. Data represent mean values from two mice
(  SD).2092 T Cell Stimulation In Vivo by LPS
Stimulation of Naive T Cells. In all of the above experi-
ments, the capacity of LPS injection to stimulate T cells
was restricted to the CD44hi subset of CD8  cells. How-
ever, this finding refers only to T cell proliferation. To ex-
amine other parameters of cell activation, T cells from
LPS-injected mice were examined 1 d later for upregula-
tion of CD69 expression, a highly sensitive indicator of T
(and B) cell activation (18). The results shown in Fig. 6 A
make three points. First, high doses of LPS caused upregu-
lation of CD69 not only on CD8  cells and B cells (as ex-
pected from the BrdU labeling studies) but also on CD4 
cells. Second, based on the results of injecting graded doses
of LPS, the sensitivity of CD8  cells, B cells, and CD4 
cells to LPS-induced CD69 upregulation seemed to be re-
markably similar. Third, with high doses of LPS, CD69
upregulation applied to a high proportion (60–80%) of total
CD4  and CD8  cells, suggesting that the LPS-stimulated
cells included naive T cells. In support of this possibility,
CD69 upregulation was clearly apparent on both CD44lo
and CD44hi T cell subsets, both for CD4  cells and CD8 
cells (Fig. 6 B). Although CD44hi cells were more sensitive
to CD69 upregulation than CD44lo cells, injection of a
high dose of LPS induced CD69 expression on  50% of
CD44lo cells, both for CD4  and CD8  cells.
Discussion
Although LPS-induced proliferation of lymphoid cells is
thought to be primarily restricted to B cells, there are a
number of reports that LPS can stimulate T cells. Thus, it is
well established that LPS can act as a powerful adjuvant for
T cell responses to specific antigen (19–21). It has also been
found that LPS can stimulate certain T cell clones and a
small proportion (1–3%) of splenic T cells in vitro (22).
However, quantitative information on the capacity of LPS
to stimulate normal T cells in vivo has not been reported.
Figure 5. Role of IFN-I in LPS-induction of CD8  T cell proliferation.
(A) Comparison of the T cell–proliferative response to LPS in control
(129) mice versus mice deficient for the IFN-IR. (B) Comparison of the
T cell proliferative response to LPS in control (B6) mice versus mice defi-
cient for IFN- . 1  g (left) or 12.5  g (right) LPS was injected intrave-
nously and mice were given BrdU water for 3 d. The results shown are
for CD8  spleen cells. Data represent mean values for 2–4 mice per point
(  SD).
Figure 6. Expression of CD69
on T and B cells after LPS injec-
tion. (A) CD69 expression on
total CD4 , CD8  and B220 
LN (left) and spleen cells (right) 1 d
after injection of either PBS or 1,
10, or 100  g LPS. Data repre-
sent mean values from two mice
per point (  SD). (B) CD69 ex-
pression on CD8  ( upper) or
CD4  (lower) LN T cells express-
ing different levels of CD44 after
injection of either PBS or 1 or
100  g LPS. The percent label-
ing shown on the right in B was
derived from an independent ex-
periment from that in A, and the
data represent mean values from
two mice per point. In both ex-
periments, PBS or LPS was in-
jected intravenously into B6 mice,
and LN and spleen cells were an-
alyzed 1 d later.2093 Tough et al.
We show here that injecting LPS into normal mice
placed on BrdU water induced substantial proliferation of
T cells. Whereas proliferation of B cells required quite high
doses of LPS (10  g), even very low doses of LPS (10 ng)
were sufficient to cause T cell proliferation. At all doses of
LPS tested, the proliferative response of T cells was re-
stricted to a single subset of T cells, namely CD44hi CD8 
cells. However, in terms of CD69 upregulation, LPS injec-
tion led to activation of nearly all T cells, including naive
(CD44lo) CD8  and CD4  cells.
The strong proliferation of CD44hi CD8  cells induced
by LPS injection correlated closely with the selective pro-
liferation of CD44hi CD8  cells seen previously in viral in-
fections and in mice injected with IFN-I or Poly I:C (9).
Hence, it is highly likely that LPS-induced proliferation of
CD44hi CD8  cells requires the production of IFN-I, pre-
sumably via a direct action of LPS on APC. A critical role
for APC is apparent from the finding that the failure of LPS
to stimulate T cell proliferation in LPS-nonresponder mice
could be overcome by coinjecting normal T-depleted
spleen cells as a source of APC. Although LPS can stimu-
late APC to produce a spectrum of different cytokines (11–
13, 23–25), it is notable that T cell stimulation after LPS
injection was substantially reduced in IFN-IR  mice,
though only with limiting doses of LPS. Therefore, the im-
plication is that LPS stimulation of CD8  cells is strongly
dependent on IFN-I production but only at moderate or low
doses of LPS. At higher LPS doses, IFN-I production is ap-
parently no longer essential, and T cell proliferation is con-
trolled by a different mechanism. Two obvious questions arise:
Does IFN-I act directly on T cells? This possibility is un-
likely because we have found no evidence that IFN-I is ca-
pable of causing proliferation of purified T cells in vitro
(our unpublished data). Moreover, based on studies with
bone marrow chimeras constructed with a mixture of nor-
mal and IFN-IR  stem cells, the inability of IFN-IR  T cells
to proliferate after IFN-I (Poly I:C) injection can be over-
come by providing a source of normal APC (our unpub-
lished data). These findings suggest that IFN-I induces T cell
proliferation by an indirect pathway involving APC. The
simplest possibility is that IFN-I stimulates APC to produce
other cytokines, which then act directly on T cells.
Which cytokines elicit T cell proliferation in vivo? Be-
cause a wide variety of different cytokines are capable of
stimulating activated T cells in vitro, defining which partic-
ular cytokines stimulate T cells after LPS injection in vivo
is a formidable task. IL-12 is a logical candidate because this
cytokine is synthesized by APC in response to LPS (13).
Moreover, we have observed strong stimulation of CD44hi
CD8  cells in mice injected with rIL-12 (our unpublished
data). Nevertheless, we have seen only minimal prolifera-
tion of T cells after culture with IL-12 in vitro. Hence, as
with IFN-I, it is doubtful whether IL-12 acts directly on T
cells. In considering other cytokines, IL-15 is of special in-
terest because this IL-2–like cytokine is produced by APC
and, like IL-2, IL-15 is directly stimulatory for activated T
cells in vitro (25, 26). Experiments with IL-15 (and various
other cytokines) are currently underway.
Because LPS is a major component of gram-negative
bacteria, one would expect to see prominent evidence of T
cell proliferation during bacterial infections. In fact, as with
LPS, we have found that injecting mice with killed Brucella
abortus causes marked proliferation of CD44hi CD8  cells
(our unpublished data). However, in contrast with LPS, B.
abortus induces T cell proliferation in both normal and
LPS-nonresponder mice, indicating that T cell stimulation
by bacteria is not controlled solely by LPS. Hence, bearing
in mind that bystander stimulation of CD44hi CD8  cells is
also conspicuous in viral infections (9), it would seem quite
likely that many different products of infectious micro-
organisms have the capacity to stimulate memory-pheno-
type T cells in vivo. However, in normal animals it is notable
that the background rate of proliferation of memory–phe-
notype T cells is substantially higher for CD4  cells than
for CD8  cells (3). This is surprising because the stimula-
tion of CD44hi cells induced by viruses, LPS, and killed B.
abortus is heavily skewed to CD8  cells. Therefore, the im-
plication is that stimulation of CD44hi CD4  cells is con-
trolled by a separate mechanism. In this respect, prelimi-
nary work has shown that certain bacteria induce poor
proliferation of CD44hi CD8  cells in vivo but strong pro-
liferation of CD44hi CD4  cells (our unpublished data).
Which cytokines control the proliferation of CD44hi CD4 
cells has yet to be resolved.
As a final comment, it is striking that high doses of LPS
caused marked CD69 upregulation on CD44lo (naive) cells
as well as on CD44hi cells, both for CD4  cells and CD8 
cells. How LPS induces activation of naive T cells but
without causing these cells to enter cell cycle is unknown.
Future work will be needed to resolve this paradox.
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